HUP0303665A3 - Arylated furane- and thiophene carboxylic acid amides with potassium channel blocking effect - Google Patents

Arylated furane- and thiophene carboxylic acid amides with potassium channel blocking effect

Info

Publication number
HUP0303665A3
HUP0303665A3 HU0303665A HUP0303665A HUP0303665A3 HU P0303665 A3 HUP0303665 A3 HU P0303665A3 HU 0303665 A HU0303665 A HU 0303665A HU P0303665 A HUP0303665 A HU P0303665A HU P0303665 A3 HUP0303665 A3 HU P0303665A3
Authority
HU
Hungary
Prior art keywords
arylated
furane
carboxylic acid
acid amides
potassium channel
Prior art date
Application number
HU0303665A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HUP0303665A2 publication Critical patent/HUP0303665A2/hu
Publication of HUP0303665A3 publication Critical patent/HUP0303665A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
HU0303665A 2000-12-12 2001-11-29 Arylated furane- and thiophene carboxylic acid amides with potassium channel blocking effect HUP0303665A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10061876A DE10061876A1 (de) 2000-12-12 2000-12-12 Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
PCT/EP2001/013958 WO2002048131A1 (de) 2000-12-12 2001-11-29 Arylierte furan- und thiophencarbonsäureamide mit kalium kanal blockierender wirkung

Publications (2)

Publication Number Publication Date
HUP0303665A2 HUP0303665A2 (hu) 2004-03-01
HUP0303665A3 true HUP0303665A3 (en) 2005-02-28

Family

ID=7666837

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303665A HUP0303665A3 (en) 2000-12-12 2001-11-29 Arylated furane- and thiophene carboxylic acid amides with potassium channel blocking effect

Country Status (30)

Country Link
US (1) US6982279B2 (hu)
EP (1) EP1349846B1 (hu)
JP (1) JP4252798B2 (hu)
KR (1) KR20030061846A (hu)
CN (1) CN1225463C (hu)
AR (1) AR032781A1 (hu)
AT (1) ATE288906T1 (hu)
AU (2) AU2002235743B2 (hu)
BR (1) BR0116084A (hu)
CA (1) CA2431095A1 (hu)
CZ (1) CZ20031633A3 (hu)
DE (2) DE10061876A1 (hu)
DK (1) DK1349846T3 (hu)
EE (1) EE05306B1 (hu)
ES (1) ES2236335T3 (hu)
HK (1) HK1061850A1 (hu)
HR (1) HRP20030469A2 (hu)
HU (1) HUP0303665A3 (hu)
IL (2) IL156314A0 (hu)
MX (1) MXPA03004770A (hu)
NO (1) NO329163B1 (hu)
NZ (1) NZ526383A (hu)
PL (1) PL362410A1 (hu)
PT (1) PT1349846E (hu)
RS (1) RS50336B (hu)
RU (1) RU2275366C2 (hu)
SK (1) SK287464B6 (hu)
TW (1) TWI288134B (hu)
WO (1) WO2002048131A1 (hu)
ZA (1) ZA200304091B (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12622A (en) * 2001-06-11 2006-06-12 Shire Biochem Inc Thiophene derivatives as antiviral agents for flavivirus infection.
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
ES2345438T3 (es) 2002-12-10 2010-09-23 Virochem Pharma Inc. Compuestos y metodos para el tratamiento o prevencion de infecciones por flavivirus.
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
EP1493739A1 (fr) * 2003-07-03 2005-01-05 Warner-Lambert Company LLC Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
GB0324269D0 (en) * 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
GB0412986D0 (en) 2004-06-10 2004-07-14 Xention Discovery Ltd Compounds
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
CN102718744A (zh) * 2005-05-13 2012-10-10 Viro化学制药公司 治疗或预防黄病毒感染的组合物和方法
AU2006276292B2 (en) * 2005-07-22 2010-09-16 Merck Sharp & Dohme Corp. Potassium channel inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
CN101636154B (zh) * 2006-04-27 2011-12-14 塞诺菲-安万特德国有限公司 Task-1和task-3离子通道抑制剂
EP2104674B8 (en) 2006-11-15 2013-10-02 Vertex Pharmaceuticals (Canada) Incorporated Thiophene analogues for the treatment or prevention of flavivirus infections
CA2699157A1 (en) * 2007-09-10 2009-03-19 Calcimedica, Inc. Compounds that modulate intracellular calcium
ITMI20071971A1 (it) * 2007-10-10 2009-04-11 Altergon Sa Composizione farmaceutica per la somministrazione sublinguale di progesterone, e metodo per la sua preparazione
WO2009076454A2 (en) 2007-12-12 2009-06-18 Calcimedica, Inc. Compounds that modulate intracellular calcium
MY157445A (en) 2008-08-27 2016-06-15 Calcimedica Inc Compounds that modulate intracellular calcium.
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
US8524763B2 (en) 2008-09-22 2013-09-03 Calcimedica, Inc. Inhibitors of store operated calcium release
US8143269B2 (en) 2008-10-03 2012-03-27 Calcimedica, Inc. Inhibitors of store operated calcium release
EA018907B1 (ru) * 2009-01-30 2013-11-29 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Кристаллический гидрохлорид n-{(1s)-2-амино-1-[(3-фторфенил)метил]этил}-5-хлор-4-(4-хлор-1-метил-1h-пиразол-5-ил)-2-тиофенкарбоксамида
WO2011034962A2 (en) 2009-09-16 2011-03-24 Calcimedica Inc. Compounds that modulate intracellular calcium
WO2011156321A1 (en) 2010-06-07 2011-12-15 Novomedix, Llc Furanyl compounds and the use thereof
MX337711B (es) 2010-08-27 2016-03-15 Calcimedica Inc Compuestos que modulan el calcio intracelular.
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (hu) 2011-07-01 2018-04-28
US20150045305A1 (en) 2012-01-27 2015-02-12 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
US9512116B2 (en) 2012-10-12 2016-12-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
CN103012381B (zh) * 2013-01-10 2015-01-07 山东大学 苯基呋喃类化合物、其制备方法及在制备抗心律失常药物中的应用
KR101721490B1 (ko) * 2014-07-30 2017-03-30 한국생명공학연구원 페닐 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 세포증식성 질병의 예방 또는 치료용 약학적 조성물
EP3366683A1 (en) * 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
DK41193D0 (da) * 1993-04-07 1993-04-07 Neurosearch As Ionkanalaabnere
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5670504A (en) 1995-02-23 1997-09-23 Merck & Co. Inc. 2,6-diaryl pyridazinones with immunosuppressant activity
US6083986A (en) 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5935945A (en) 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US6013664A (en) * 1996-11-27 2000-01-11 Bayer Aktiengesellschaft Microbicidal agents based on thiophene-2-carboxylic acid derivatives
BR9811828A (pt) * 1997-08-05 2000-08-15 American Home Prod Análogos do ácido antranìlico
DK1040108T3 (da) * 1997-12-19 2004-05-24 Schering Ag Orthoanthranilamidderivater som antikoagulanter
US6333337B1 (en) * 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
AU2300699A (en) * 1998-02-17 1999-08-30 Ono Pharmaceutical Co. Ltd. Amidino derivatives and drugs containing the same as the active ingredient
EP0960882A1 (en) * 1998-05-19 1999-12-01 Hoechst Marion Roussel Deutschland GmbH Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
EP1082315A1 (en) 1998-06-05 2001-03-14 Icagen, Inc. Potassium channel inhibitors
EP1109544A4 (en) 1998-09-01 2004-10-27 Bristol Myers Squibb Co POTASSIUM CHANNEL INHIBITORS AND THEIR METHOD OF USE
US6274620B1 (en) * 1999-06-07 2001-08-14 Biochem Pharma Inc. Thiophene integrin inhibitors
WO2003018585A1 (en) * 2001-08-24 2003-03-06 Pharmacia & Upjohn Company Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease

Also Published As

Publication number Publication date
CN1225463C (zh) 2005-11-02
MXPA03004770A (es) 2003-09-10
EE05306B1 (et) 2010-06-15
AR032781A1 (es) 2003-11-26
TWI288134B (en) 2007-10-11
US6982279B2 (en) 2006-01-03
ES2236335T3 (es) 2005-07-16
US20040068120A1 (en) 2004-04-08
EE200300240A (et) 2003-08-15
NZ526383A (en) 2004-11-26
CZ20031633A3 (cs) 2003-08-13
NO20032535L (no) 2003-07-29
ATE288906T1 (de) 2005-02-15
HUP0303665A2 (hu) 2004-03-01
HRP20030469A2 (en) 2005-04-30
DK1349846T3 (da) 2005-05-30
PT1349846E (pt) 2005-05-31
DE10061876A1 (de) 2002-06-20
RS50336B (sr) 2009-11-10
SK287464B6 (sk) 2010-10-07
EP1349846B1 (de) 2005-02-09
AU2002235743B2 (en) 2006-07-20
JP2004526680A (ja) 2004-09-02
IL156314A0 (en) 2004-01-04
KR20030061846A (ko) 2003-07-22
NO329163B1 (no) 2010-08-30
HK1061850A1 (en) 2004-10-08
EP1349846A1 (de) 2003-10-08
PL362410A1 (en) 2004-11-02
NO20032535D0 (no) 2003-06-04
AU3574302A (en) 2002-06-24
CN1479734A (zh) 2004-03-03
ZA200304091B (en) 2004-04-23
YU42503A (sh) 2006-05-25
IL156314A (en) 2008-12-29
SK7252003A3 (en) 2003-12-02
JP4252798B2 (ja) 2009-04-08
DE50105337D1 (de) 2005-03-17
WO2002048131A1 (de) 2002-06-20
BR0116084A (pt) 2003-10-14
CA2431095A1 (en) 2002-06-20
RU2275366C2 (ru) 2006-04-27

Similar Documents

Publication Publication Date Title
HUP0303665A3 (en) Arylated furane- and thiophene carboxylic acid amides with potassium channel blocking effect
AU2002235743A1 (en) Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect
DE60131179D1 (en) Hydroxamate-derivate als deacetylase inhibitoren
AU9502901A (en) Video interaction
IL155912A0 (en) Fet with notched gate
AU4794301A (en) Nonwovens modified with petrolatum
DE60134697D1 (de) Befestigungselement mit U-förmiger Mutter
AU5029601A (en) Crosslinkable polyethylene composition
AU2486102A (en) Mild cosmetic composition with stabilized retinoids
EP1338806A4 (en) CLAMPING DEVICE WITH EASY EFFECT
AU7641701A (en) Overcap closures with rolled apron
HUP0102960A3 (en) Injection-type anchor
SI1349846T1 (en) Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect
IL154633A0 (en) Substituted phenylcyclohexane carboxylic acid amides and the use thereof
GB0216544D0 (en) Direct coal-based continuous steelmaking
GB9923950D0 (en) Strip easy
GB0009554D0 (en) Strip
PL357012A1 (en) Novel alpha-sulfin- and alpha-sulfonamino acid amides
GB0030452D0 (en) Continuous strip
AU141199S (en) An irrigation gate
GB0014967D0 (en) Travel wrap
GB0021717D0 (en) Gate
GB0003087D0 (en) Round baler
TW415165U (en) Improved fishing line tightening device
TW420097U (en) Crystal ball structure improvement

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished